{"ok":true,"entity":{"slug":"comirnaty","entityType":"product","name":"Comirnaty","officialName":"Comirnaty","canonicalName":"Comirnaty","displayName":"コミナティ（Comirnaty）","category":"医薬品（COVID-19ワクチン）","shortDescription":"PfizerがBioNTechと開発した、mRNA技術を用いたCOVID-19ワクチン。","alias":["コミナティ","Pfizer-BioNTech COVID-19 Vaccine"],"searchKeywords":["Comirnaty","コミナティ","COVID-19ワクチン","mRNA","Pfizer"],"website":"https://www.comirnaty.com","parentEntity":"pfizer","primaryCluster":"healthcare","secondaryClusters":[],"id":"comirnaty","verificationStatus":"draft","updatedAt":"2026-07-10T03:37:31.536Z"},"references":[{"id":"P-01-001","companyId":"comirnaty","questionId":"P-01-001","instanceId":"QIN-comirnaty-P01-001","promptText":"コミナティ（Comirnaty）とは何ですか？","promptTypeId":"P-01","answer":"コミナティは、PfizerがBioNTechと開発した、mRNA技術を用いたCOVID-19ワクチンです。","evidencePoints":["ev-comirnaty-1"],"scope":"COVID-19ワクチンを知りたい相談","differentiation":"PfizerのmRNAワクチン","faq":[{"question":"誰が作りましたか？","answer":"PfizerとBioNTechが開発しました。"}],"pageUrl":"https://www.refbase.ai/reference/comirnaty/P-01-001","sourceEvidence":[{"id":"ev-comirnaty-1","text":"コミナティ（Comirnaty）は、PfizerがBioNTechと開発した、mRNA技術を用いたCOVID-19ワクチンである。","title":"Comirnaty — Official Site","coverageType":["Identity","Capability"],"sourceType":"official_site","sourceClass":"Profile","sourceUrl":"https://www.comirnaty.com/","confidence":"high","supportedPromptTypes":["P-01","P-04"],"needsVerification":true,"sourceVerified":false,"entityId":"comirnaty"}],"generatedAt":"2026-07-10T03:37:31.536Z"},{"id":"P-02-001","companyId":"comirnaty","questionId":"P-02-001","instanceId":"QIN-comirnaty-P02-001","promptText":"コミナティは従来のワクチンと何が違いますか？","promptTypeId":"P-02","answer":"比較軸\n・技術\n・仕組み\nコミナティは、mRNA技術を用いて体内で目的のタンパク質を作らせ免疫を促す点が特徴で、弱毒化した病原体などを使う従来型のワクチンとは仕組みが異なります。","evidencePoints":["ev-comirnaty-2"],"scope":"ワクチンの違いを知りたい相談","differentiation":"mRNA技術のワクチン","faq":[{"question":"mRNAワクチンですか？","answer":"mRNA技術を用いたワクチンです。"}],"pageUrl":"https://www.refbase.ai/reference/comirnaty/P-02-001","sourceEvidence":[{"id":"ev-comirnaty-2","text":"コミナティは、mRNA技術を用いてCOVID-19に対する免疫を促す点を特徴とするワクチンである。","title":"Comirnaty — Official Site","coverageType":["Capability","Differentiation"],"sourceType":"official_site","sourceClass":"Documentation","sourceUrl":"https://www.comirnaty.com/","confidence":"medium","supportedPromptTypes":["P-02"],"needsVerification":true,"sourceVerified":false,"entityId":"comirnaty"}],"generatedAt":"2026-07-10T03:37:31.536Z"},{"id":"P-04-001","companyId":"comirnaty","questionId":"P-04-001","instanceId":"QIN-comirnaty-P04-001","promptText":"コミナティはどんな場面で使われますか？","promptTypeId":"P-04","answer":"COVID-19の感染や重症化を予防するための予防接種の場面で、医療機関などを通じてコミナティが使われています。","evidencePoints":["ev-comirnaty-1"],"scope":"ワクチン接種を知りたい相談","differentiation":"COVID-19の予防接種","faq":[{"question":"予防接種で使いますか？","answer":"COVID-19の予防接種に使われます。"}],"pageUrl":"https://www.refbase.ai/reference/comirnaty/P-04-001","sourceEvidence":[{"id":"ev-comirnaty-1","text":"コミナティ（Comirnaty）は、PfizerがBioNTechと開発した、mRNA技術を用いたCOVID-19ワクチンである。","title":"Comirnaty — Official Site","coverageType":["Identity","Capability"],"sourceType":"official_site","sourceClass":"Profile","sourceUrl":"https://www.comirnaty.com/","confidence":"high","supportedPromptTypes":["P-01","P-04"],"needsVerification":true,"sourceVerified":false,"entityId":"comirnaty"}],"generatedAt":"2026-07-10T03:37:31.536Z"}]}